KIR3DL1 and acute myeloid leukemia: Conversely, a multicenter analysis demonstrated a significant and substantial survival benefit for AML patients receiving grafts from unrelated donors having 1 or 2 KIR B haplotypes, thus providing evidence that donors with KIR B haplotype should be used preferentially in HLA-matched or HLA-mismatched unrelated donor transplantation (46).